2018, Number 5-6
<< Back Next >>
Rev Sanid Milit Mex 2018; 72 (5-6)
Comparison of clinical diagnostic performance versus the rapid test during two seasons of influenza
Morales-Cadena GM, Fonseca-Chávez MG, Valente-Acosta B, García-Ramírez JA, Rodríguez-Baca T
Language: Spanish
References: 17
Page: 289-294
PDF size: 212.29 Kb.
ABSTRACT
Introduction: One of the reflections of the influenza pandemic in 2009 is the priority of the early prescription of antivirals, preventing the unjustified use of antibiotics.
Objective: To describe the symptomatology that is associated more with the definitive diagnosis of Influenza and to compare the performance of the clinical diagnosis against the diagnosis thrown by the rapid test.
Material and methods: A retrospective, cross-sectional, descriptive and analytical study. All patients with presumptive diagnosis of Influenza admitted to the Emergency Service of the Hospital Español de Mexico were included in two consecutive seasons from October 2016 to March 2017 and October 2017 to March 2018. Two groups were formed of the included patients: patients with positive PCR (group A) and patients with negative PCR (group B).
Results: A total of 857 patients with presumptive clinical diagnosis of influenza were obtained, of whom 537 were confirmed with Influenza by PCR (group A) and 320 were negative for the test (group B). The syndrome consisting of cough, fever, rhinorrhea and arthralgia has a specificity of 92.2% compared to the rapid test of 99.1%.
Conclusions: The syndrome characterized by cough, fever, rhinorrhea, arthralgia present during winter months has a high specificity for an infection by the Influenza virus.
REFERENCES
Arellano R, Alfaro L, Arriaga C et al. Molecular features of influenza A (H1N1) pdm09 prevalent in Mexico during winter seasons 2012-2014. PLoS ONE. 2017; 12 (7): e0180419. https://doi.org/10.1371/journal.pone.0180419.
Kim H, Schoofs P, Anderson D et al. Cold adaptation improves the growth of seasonal influenza B vaccine viruses. Vaccine. 2014; 32: 2474-2479.
Veguilla V, López H, López I et al. A large proportion of the mexican population remained susceptible to A(H1N1) pdm09 infection one year after the emergence of 2009 influenza pandemic. PLoS ONE. 2016; 11 (3): e0150428. doi: 10.1371/journal.pone.0150428.
Ruiz C, Kuri P, Robles J. Behavior of influenza seasons in Mexico from 2010 to 2016: analysis and prospective. Gaceta Médica de México. 2017; 153: 189-196.
Barr I, McCauley J, Cox N et al. Epidemiological, antigenic and genetic characteristics of seasonal influenza A(H1N1), A(H3N2) and B influenza viruses: Basis for the WHO recommendation on the composition of influenza vaccines for use in the 2009-2010 Northern Hemisphere season. Vaccine. 2010; 28: 1156-1167.
Huízar V, Arredondo A, Caballero M et al. Decision-making process by users and providers of health care services during the AH1N1 epidemic influenza in Mexico: lessons learned and challenges ahead. Arch Med Res. 2017; 48: 276-283.
Cordova J, Macias A, Hernández M et al. The 2009 pandemic in Mexico: Experience and lessons regarding national preparedness policies for seasonal and epidemic influenza. Gac Med Mex. 2017; 153: 102-110.
Prevención, diagnóstico y tratamiento de influenza estacional. Guía de evidencias y recomendaciones. México: Secretaría de Salud, CENETEC-Salud; 2015. [Fecha de publicación 02 de julio 2015].
Hurt A, Alexander R, Hibbert J et al. Performance of six influenza rapid tests in detecting human influenza in clinical specimens. J Clin Virol. 2007; 39: 132-135.
Chartrand C, Leeflang M, Minion J et al. Accuracy of rapid influenza diagnostic tests: a meta-analysis. Ann Intern Med. 2012; 156: 500-511.
Romero L, Baker S, Puerto M et al. Mutations at highly conserved residues in influenza A(H1N1)pdm09 virus affect neuraminidase activity. Virus Res. 2016; 225: 1-9.
Martínez D, Torre L, Herrera J et al. Clinical characteristics and mortality of Influenza A H1N1 and Influenza-like illness in Mexico City in the 2013-2014 winter season. Rev Inves Clin. 2016; 68: 147-153.
Mena I, Nelson M, Quezada F et al. Origins of the 2009 H1N1 influenza pandemic in swine in Mexico. Epidemiology and global health microbiology and infectious disease. 2016. doi: 10.7554/eLife.16777.
Li X y Deem M. Influenza evolution and H3N2 vaccine effectiveness, with application to the 2014/2015 season. Protein Eng Des Sel. 2016; 29: 309-316.
Monto A, Gravenstein S, Elliott M et al. Clinical signs and symptoms predicting influenza infection. Arch Intern Med. 2000; 160: 3243-3247.
Bolvin G, Hardy I, Tellier G et al. Predicting influenza infections during epidemics with use of a clinical case definition. Clin Infect Dis. 2000; 31: 1166-1169.
Uso de la vacuna antiinfluenza en la prevención de neumonía en el adulto mayor. México: Secretaría de Salud; 12 diciembre 2013.